Sernova Biotherapeutics (OTCMKTS:SEOVF) Issues Earnings Results, Meets Estimates

Sernova Biotherapeutics (OTCMKTS:SEOVF) issued its earnings results on Thursday. The company reported ($0.01) earnings per share for the quarter, hitting analysts’ consensus estimates of ($0.01), Zacks reports.

Sernova Biotherapeutics Stock Up 3.8%

Shares of SEOVF stock traded up $0.00 on Thursday, reaching $0.10. The stock had a trading volume of 213,800 shares, compared to its average volume of 47,965. Sernova Biotherapeutics has a 12 month low of $0.07 and a 12 month high of $0.14. The firm has a market capitalization of $38.52 million, a price-to-earnings ratio of -2.55 and a beta of 0.86. The firm’s 50-day moving average is $0.08 and its two-hundred day moving average is $0.10.

About Sernova Biotherapeutics

Sernova Biotherapeutics is a clinical‐stage biotechnology company focused on developing and commercializing cell‐based therapeutic technologies for patients with chronic and life‐threatening diseases. Headquartered in London, Ontario, Canada, the firm is advancing an implantable device platform designed to support the long-term survival and function of therapeutic cells. The company’s lead product candidate, known as the Cell Pouch System, is engineered to create a vascularized environment in which transplanted cells can thrive, with an initial emphasis on treating patients with type 1 diabetes.

In its core program, Sernova has initiated a Phase I/II clinical trial evaluating the safety and efficacy of the Cell Pouch System in individuals with type 1 diabetes who require islet cell transplantation.